Accuray (ARAY) Stock Forecast, Price Target & Predictions
ARAY Stock Forecast
Accuray stock forecast is as follows: an average price target of $6.00 (represents a 220.86% upside from ARAY’s last price of $1.87) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
ARAY Price Target
The average price target for Accuray (ARAY) is $6.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 220.86% upside from ARAY's last price of $1.87.
ARAY Analyst Ratings
According to 1 Wall Street analysts, Accuray's rating consensus is 'Buy'. The analyst rating breakdown for ARAY stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Accuray Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 02, 2024 | Maria Thibault | BTIG | $6.00 | $2.17 | 176.50% | 220.86% |
| Jun 24, 2022 | BTIG | $7.00 | $2.23 | 214.61% | 274.33% |
The latest Accuray stock forecast, released on May 02, 2024 by Maria Thibault from BTIG, set a price target of $6.00, which represents a 176.50% increase from the stock price at the time of the forecast ($2.17), and a 220.86% increase from ARAY last price ($1.87).
Accuray Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $6.00 |
| Last Closing Price | $1.87 | $1.87 | $1.87 |
| Upside/Downside | -100.00% | -100.00% | 220.86% |
In the current month, the average price target of Accuray stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Accuray's last price of $1.87. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 02, 2024 | BTIG | Buy | Buy | Hold |
| Jun 24, 2022 | BTIG | Buy | Buy | Hold |
Accuray's last stock rating was published by BTIG on May 02, 2024. The company gave ARAY a "Buy" rating, the same as its previous rate.
Accuray Financial Forecast
Accuray Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $107.24M | $103.89M | $118.29M | $118.06M | $114.76M | $96.49M | $110.02M | $96.17M | $116.28M | $107.44M | $110.94M | $102.56M | $97.46M | $85.33M | $94.98M | $99.55M | $98.83M | $89.58M | $117.42M | $103.22M |
| Avg Forecast | $142.53M | $128.00M | $113.84M | $106.38M | $143.14M | $111.85M | $110.34M | $97.55M | $121.50M | $115.96M | $106.67M | $97.62M | $121.75M | $109.77M | $107.03M | $99.94M | $105.32M | $96.05M | $103.32M | $93.86M | $102.04M | $99.27M | $92.34M | $83.72M | $91.56M | $97.26M | $97.73M | $92.15M | $116.37M | $103.95M |
| High Forecast | $147.67M | $132.61M | $117.94M | $110.21M | $148.30M | $114.57M | $111.98M | $101.06M | $121.50M | $115.96M | $107.07M | $99.30M | $126.14M | $113.73M | $110.88M | $99.94M | $105.32M | $96.05M | $103.32M | $93.86M | $102.04M | $99.27M | $92.34M | $83.72M | $91.56M | $97.26M | $97.73M | $92.15M | $116.37M | $103.95M |
| Low Forecast | $138.58M | $124.45M | $110.68M | $103.43M | $139.17M | $109.13M | $108.70M | $94.84M | $121.50M | $115.96M | $106.26M | $96.30M | $118.37M | $106.73M | $104.06M | $99.94M | $105.32M | $96.05M | $103.32M | $93.86M | $102.04M | $99.27M | $92.34M | $83.72M | $91.56M | $97.26M | $97.73M | $92.15M | $116.37M | $103.95M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.06% | 0.97% | 1.08% | 1.07% | 0.97% | 1.04% | 1.00% | 1.13% | 1.14% | 1.09% | 1.03% | 1.06% | 1.02% | 1.04% | 1.02% | 1.01% | 0.97% | 1.01% | 0.99% |
Accuray's average Quarter revenue forecast for Mar 24 based on 1 analysts is $115.96M, with a low forecast of $115.96M, and a high forecast of $115.96M. ARAY's average Quarter revenue forecast represents a 8.14% increase compared to the company's last Quarter revenue of $107.24M (Dec 23).
Accuray EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-3.96M | $2.21M | $-457.00K | $2.32M | $2.71M | $-2.18M | $2.05M | $1.11M | $2.08M | $822.00K | $-9.20M | $1.91M | $6.71M | $2.41M | $2.07M | $4.78M | $13.24M | $-6.85M | $3.87M | $966.00K |
| Avg Forecast | $5.44M | $4.88M | $4.34M | $4.06M | $5.46M | $4.27M | $4.21M | $3.72M | $4.63M | $1.93M | $4.07M | $3.72M | $4.64M | $1.52M | $25.42M | $2.51M | $2.65M | $1.20M | $2.60M | $2.36M | $-9.20M | $2.50M | $2.32M | $2.11M | $2.30M | $11.83M | $2.46M | $2.32M | $2.93M | $1.52M |
| High Forecast | $5.63M | $5.06M | $4.50M | $4.20M | $5.66M | $4.37M | $4.27M | $3.85M | $4.63M | $2.31M | $4.08M | $3.79M | $4.81M | $1.83M | $30.50M | $2.51M | $2.65M | $1.44M | $2.60M | $2.36M | $-7.36M | $2.50M | $2.32M | $2.11M | $2.30M | $14.19M | $2.46M | $2.32M | $2.93M | $1.83M |
| Low Forecast | $5.29M | $4.75M | $4.22M | $3.94M | $5.31M | $4.16M | $4.15M | $3.62M | $4.63M | $1.54M | $4.05M | $3.67M | $4.51M | $1.22M | $20.34M | $2.51M | $2.65M | $962.64K | $2.60M | $2.36M | $-11.03M | $2.50M | $2.32M | $2.11M | $2.30M | $9.46M | $2.46M | $2.32M | $2.93M | $1.22M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | -0.97% | 0.59% | -0.10% | 1.52% | 0.11% | -0.87% | 0.77% | 0.92% | 0.80% | 0.35% | 1.00% | 0.76% | 2.89% | 1.14% | 0.90% | 0.40% | 5.39% | -2.96% | 1.32% | 0.63% |
2 analysts predict ARAY's average Quarter EBITDA for Dec 23 to be $4.07M, with a high of $4.08M and a low of $4.05M. This is 83.84% upper than Accuray's previous annual EBITDA (Sep 23) of $2.21M.
Accuray Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-9.62M | $-2.97M | $-2.56M | $599.00K | $-1.87M | $-5.45M | $-3.45M | $-1.05M | $179.00K | $-1.03M | $-11.09M | $-390.00K | $4.77M | $402.00K | $-152.00K | $2.63M | $10.71M | $-9.36M | $-1.40M | $-1.18M |
| Avg Forecast | $10.01M | $3.45M | $881.98K | $-430.97K | $5.07M | $-230.52K | $-2.73M | $-5.01M | $3.01M | $-2.64M | $-3.79M | $-5.01M | $1.00M | $-2.08M | $18.06M | $-3.09M | $-6.06M | $-1.65M | $404.11K | $-3.82M | $-11.09M | $-404.11K | $-836.01K | $-7.41M | $-3.79M | $6.50M | $-6.82M | $-9.50M | $1.46M | $-1.86M |
| High Forecast | $10.48M | $3.61M | $923.27K | $-415.43K | $5.31M | $-222.21K | $-2.05M | $-4.83M | $3.15M | $-2.11M | $-3.57M | $-3.01M | $1.05M | $-1.67M | $21.67M | $-3.09M | $-6.06M | $-1.32M | $404.11K | $-3.82M | $-8.87M | $-404.11K | $-836.01K | $-7.41M | $-3.79M | $7.80M | $-6.82M | $-9.50M | $1.46M | $-1.49M |
| Low Forecast | $9.65M | $3.32M | $850.18K | $-451.14K | $4.89M | $-241.31K | $-3.42M | $-5.25M | $2.90M | $-3.16M | $-4.01M | $-8.02M | $966.12K | $-2.50M | $14.45M | $-3.09M | $-6.06M | $-1.98M | $404.11K | $-3.82M | $-13.31M | $-404.11K | $-836.01K | $-7.41M | $-3.79M | $5.20M | $-6.82M | $-9.50M | $1.46M | $-2.24M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 2.54% | 0.59% | -2.55% | -0.29% | -0.10% | 1.76% | 0.57% | 0.63% | 0.44% | 0.27% | 1.00% | 0.97% | -5.70% | -0.05% | 0.04% | 0.40% | -1.57% | 0.99% | -0.96% | 0.63% |
Accuray's average Quarter net income forecast for Jun 23 is $1.00M, with a range of $966.12K to $1.05M. ARAY's average Quarter net income forecast represents a 67.32% increase compared to the company's last Quarter net income of $599.00K (Mar 23).
Accuray SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $24.59M | $23.27M | $23.95M | $22.19M | $25.62M | $22.69M | $26.40M | $20.97M | $23.95M | $22.73M | $24.23M | $21.85M | $20.68M | $17.79M | $22.30M | $20.00M | $21.21M | $23.88M | $26.62M | $24.67M |
| Avg Forecast | $30.82M | $27.68M | $24.61M | $23.00M | $30.95M | $24.18M | $23.86M | $21.09M | $26.27M | $52.86M | $23.06M | $21.11M | $26.32M | $41.78M | $78.29M | $21.61M | $22.77M | $33.03M | $22.34M | $20.29M | $24.23M | $21.46M | $19.96M | $18.10M | $19.80M | $49.50M | $21.13M | $19.92M | $25.16M | $38.86M |
| High Forecast | $31.93M | $28.67M | $25.50M | $23.83M | $32.06M | $24.77M | $24.21M | $21.85M | $26.27M | $63.43M | $23.15M | $21.47M | $27.27M | $50.14M | $93.95M | $21.61M | $22.77M | $39.64M | $22.34M | $20.29M | $29.08M | $21.46M | $19.96M | $18.10M | $19.80M | $59.40M | $21.13M | $19.92M | $25.16M | $46.63M |
| Low Forecast | $29.96M | $26.91M | $23.93M | $22.36M | $30.09M | $23.59M | $23.50M | $20.51M | $26.27M | $42.29M | $22.98M | $20.82M | $25.59M | $33.43M | $62.64M | $21.61M | $22.77M | $26.42M | $22.34M | $20.29M | $19.39M | $21.46M | $19.96M | $18.10M | $19.80M | $39.60M | $21.13M | $19.92M | $25.16M | $31.09M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.10% | 0.91% | 0.53% | 0.33% | 1.05% | 1.16% | 0.63% | 1.07% | 1.12% | 1.00% | 1.02% | 1.04% | 0.98% | 1.13% | 0.40% | 1.00% | 1.20% | 1.06% | 0.63% |
Accuray's average Quarter SG&A projection for Mar 24 is $52.86M, based on 1 Wall Street analysts, with a range of $42.29M to $63.43M. The forecast indicates a 115.00% rise compared to ARAY last annual SG&A of $24.59M (Dec 23).
Accuray EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-0.10 | $-0.03 | $-0.03 | $0.01 | $-0.02 | $-0.06 | $-0.04 | $-0.01 | - | $-0.01 | $-0.12 | $-0.00 | $0.05 | - | $-0.00 | $0.03 | $0.12 | $-0.11 | $-0.02 | $-0.01 |
| Avg Forecast | $0.10 | $0.03 | $0.01 | $-0.00 | $0.05 | $-0.00 | $-0.03 | $-0.05 | $0.03 | $-0.02 | $-0.04 | $-0.05 | $0.01 | $-0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.06 | - | $-0.04 | $-0.02 | $-0.00 | $-0.01 | $-0.07 | $-0.04 | $-0.04 | $-0.07 | $-0.09 | $0.01 | $-0.04 |
| High Forecast | $0.10 | $0.04 | $0.01 | $-0.00 | $0.05 | $-0.00 | $-0.02 | $-0.05 | $0.03 | $-0.02 | $-0.04 | $-0.03 | $0.01 | $-0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.06 | - | $-0.04 | $-0.02 | $-0.00 | $-0.01 | $-0.07 | $-0.04 | $-0.04 | $-0.07 | $-0.09 | $0.01 | $-0.04 |
| Low Forecast | $0.10 | $0.03 | $0.01 | $-0.00 | $0.05 | $-0.00 | $-0.03 | $-0.05 | $0.03 | $-0.02 | $-0.04 | $-0.08 | $0.01 | $-0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.06 | - | $-0.04 | $-0.02 | $-0.00 | $-0.01 | $-0.07 | $-0.04 | $-0.04 | $-0.07 | $-0.09 | $0.01 | $-0.04 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 2.60% | 0.61% | -2.66% | -0.86% | 0.75% | 1.90% | 0.62% | 0.20% | 0.50% | 0.26% | 5.45% | 1.05% | -6.04% | -0.06% | 0.04% | -0.75% | -1.78% | 1.17% | -1.38% | 0.25% |
According to 4 Wall Street analysts, Accuray's projected average Quarter EPS for Jun 23 is $0.01, with a low estimate of $0.01 and a high estimate of $0.01. This represents a 0.00% decrease compared to ARAY previous annual EPS of $0.01 (Mar 23).
Accuray Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CTSO | Cytosorbents | $0.81 | $9.00 | 1011.11% | |
| APYX | Apyx Medical | $1.64 | $8.50 | 418.29% | Buy |
| ARAY | Accuray | $1.91 | $6.00 | 214.14% | Buy |
| TELA | TELA Bio | $2.76 | $8.00 | 189.86% | Buy |
| CUTR | Cutera | $0.35 | $1.00 | 185.71% | Hold |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| SIBN | SI-BONE | $13.84 | $18.50 | 33.67% | Buy |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| AVNS | Avanos Medical | $17.02 | $20.00 | 17.51% | Hold |
| FNA | Paragon 28 | $10.36 | $11.50 | 11.00% | Buy |
| BVS | Bioventus | $11.15 | $12.00 | 7.62% | Buy |
| AORT | Artivion | $28.90 | $30.75 | 6.40% | Buy |
| SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |
| CLPT | ClearPoint Neuro | $16.34 | $15.00 | -8.20% | Buy |